Țară: Malaezia
Limbă: engleză
Sursă: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Magnesium Trisilicate; Aluminium hydroxide
IDAMAN PHARMA MANUFACTURING SDN BHD
Magnesium Trisilicate; Aluminium hydroxide
30 Tablets
IDAMAN PHARMA MANUFACTURING SDN BHD
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ IDAMAN PHARMA MAGNESIUM TRISILICATE TABLET COMPOUND Magnesium Trisilicate (250mg) and Dried Aluminium Hydroxide (120mg) 1 WHAT IS IN THIS LEAFLET 1. What Idaman Pharma Magnesium Trisilicate Tablet Compound is used for 2. How Idaman Pharma Magnesium Trisilicate Tablet Compound works 3. Before you use Magnesium Trisilicate Tablet Compound 4. How to use Idaman Pharma Magnesium Trisilicate Tablet Compound 5. While you are using Idaman Pharma Magnesium Trisilicate Tablet Compound 6. Side Effects 7. Storage and Disposal of Idaman Pharma Magnesium Trisilicate Tablet Compound 8. Product Description 9. Product Registration Holder and Manufacturer 10. Date of Revision WHAT IDAMAN PHARMA MAGNESIUM TRISILICATE TABLET COMPOUND IS USED FOR Idaman Pharma Magnesium Trisilicate Tablet Compound contains a group of medicine called antacids. This medicine is indicated for following treatments: - • For symptomatic relief of stomach upset associated with hyperacidity (heart burn, acid indigestion and sour stomach). • For hyperacidity associated with gastric and duodenal ulcers. • For symptomatic treatment of gastroesophageal reflux disease (long term condition where acid from the stomach comes up into the esophagus). HOW IDAMAN PHARMA MAGNESIUM TRISILICATE TABLET COMPOUND WORKS Idaman Pharma Magnesium Trisilicate Tablet Compound is a medicine that helps correct the pH balance in the stomach. The stomach has its own natural acids and sometimes these acids become too much and it is become too acidic. Idaman Pharma Magnesium Trisilicate Tablet Compound works to neutralize or buffer existing quantities of stomach acid and reduces acid concentration within the lumen of the oesophagus. BEFORE YOU USE IDAMAN PHARMA MAGNESIUM TRISILICATE TABLET COMPOUND - _When you must not use it _ Idaman Pharma Magnesium Trisilicate Tablet Compound should not be given to patients with following conditions: • In patients with kidney problem. • To young children (up to 6 years of age), unless prescr Citiți documentul complet
IDAMAN PHARMA MANUFACTURING IDAMAN PHARMA MAGNESIUM TRISILICATE TABLET COMPOUND DESCRIPTION Round, flat, bevel edged tablets and scored on one side. Colour: W hite EACH TABLET CONTAINS: Magnesium Trisilicate 250 mg Dried Aluminium Hydroxide 120 mg _Preservative: _ Sodium Benzoate: 0.27mg ROUTE OF ADMINISTRATION Oral PHARMACODYNAMICS Magnesium Trisilicate and Dried Aluminium Hydroxide are both slow acting antacids and absorption from the gut of breakdown products is very limited. The action is virtually entirely the inactivation of gastric acid and the symptomatic relief in gastric hyper acidic peptic ulcers. The reaction of the trisilicate is slow and prolonged, and the silica formed is in the gelatinous colloidal state. The antacid action is accordingly slow in onset but it is prolonged and powerful. The absorbent properties of the product are possibly due to the formation of the silica gel, which provides a protective coating over the walls of the stomach. Aluminium Hydroxide has neutralising and absorbent actions. It does not completely neutralise the stomach contents, but the pH achieved (3.4 to 4.0) is sufficient to inhibit the proteolytic action of pepsin. There is also some evidence that the aluminium ion may inhibit pepsin action independently of its pH effect. PHARMACOKINETICS Aluminium and Magnesium ions are not completely absorbed. Unreacted insoluble antacids pass through the intestines largely as such and are excreted in the faeces. The reacted portion of the antacids enters the intestine in the form of the cation. In the intestine, some of the cation is absorbed; that which is absorbed has the same effect on the systemic bicarbonate pool as an equivalent amount of NaHCO 3 because an equivalent amount of HCO 3 returns to the systemic bicarbonate pool. Unabsorbed cation does not spare enteric NaHCO 3 because an equivalent amount of HCO 3 or CO 2 is consumed in the formation of insoluble Hydroxides or Carbonates. Al 3+ may be thought of as reacting with CO3 2 ' to form an unstable AI 2 (CO2) 3 intermed Citiți documentul complet